Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy
|ClinicalTrials.gov Identifier: NCT00813059|
Recruitment Status : Unknown
Verified February 2012 by Edward Margolin, Mount Sinai Hospital, Canada.
Recruitment status was: Recruiting
First Posted : December 22, 2008
Last Update Posted : February 8, 2012
Mount Sinai Hospital, Canada
Information provided by (Responsible Party):
Edward Margolin, Mount Sinai Hospital, Canada
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||June 2012|
|Estimated Study Completion Date :||June 2012|
Bennett JL, Thomas S, Olson JL, Mandava N. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol. 2007 Sep;27(3):238-40.
Kelman SE. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study? J Neuroophthalmol. 2007 Sep;27(3):161-3.